A Clinical Trial of Lurasidone in Treatment of Schizophrenia
Clinical trial NCT02002832 · COMPLETED
Trial details
- NCT number
- NCT02002832
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-04-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.